GSP Neonatal IRT kit

The diagnosis of cystic fibrosis is often based on the symptoms, which may cause considerable delays in the disease intervention, and evidence indicates that early attention may be important in determining the clinical outcome. The amount of the pan

See More Details

Description
Specs
Related Products

Provide Content Correction

Product Name	Description	Item#	QTY
GSP Neonatal IRT kit	The GSP Neonatal IRT assay allows the quantitative determination of IRT from dried blood spot specimens, and is intended as an aid in screening for cystic fibrosis. The diagnosis of cystic fibrosis is often based on the symptoms, which may cause co	2013-3306001U	EA
GSP Neonatal Phenylalanine kit	Phenylketonuria (PKU) is a disorder of amino acid metabolism with reported incidence ranging from 1 in 19,000 to 1 in 13,500 newborn infants*. It is caused by an inability to convert phenylalanine to tyrosine due to deficient activity of the enzyme,	2013-33080010	EA
GSP Neonatal Biotinidase kit	The GSP Neonatal Biotinidase assay is intended for the quantitative determination of biotinidase activity in blood specimens dried on filter paper as an aid in screening newborns for biotinidase deficiency by using the GSP instrument. The incidence	2013-3307001U	EA
GSP Neonatal hTSH kit	The Revvity GSP Neonatal hTSH assay is used with dried blood spot specimens as an aid in screening newborns for congenital hypothyroidism. Congenital hypothyroidism (CH) results from a failure of the thyroid glands to produce thyroid hormones in ad	2013-3301001U	EA
GSP Neonatal GALT kit	The GSP Neonatal GALT assay is used as an aid in screening newborns for classic galactosemia caused by GALT deficiency using the GSP instrument. Galactosemia is an inherited disorder caused by a deficiency of one of three enzymes responsible for t	2013-3303001U	EA

Back to Previous Page

GSP Neonatal IRT kit

REVVITY